John Whelan: Coronavirus focus falls on major pharma firms and their links to China

As the World Health Organisation scrambles for a cure to the Coronavirus, a further crisis is simmering: The global dependence on China for the production of key ingredients in the global supply chain for antibiotics, diabetes drugs, painkillers and also many electronic components for medical devices.

The Chinese city of Wuhan, at the epicentre of the Coronavirus, is a significant player in the biotechnology and pharmaceutical industry, with multiple pharmaceutical companies located in the city.